Protein Is Key To Embryonic Stem Cell Differentiation
ScienceDaily (Mar. 25, 2009)
Investigators at Burnham Institute for Medical Research (Burnham) have learned that a protein called Shp2 plays a critical role in the pathways that control decisions for differentiation or self-renewal in both human embryonic stem cells (hESCs) and mouse embryonic stem cells (mESCs).
Maryland: Senate budget panel suggests cuts in stem cell research
Baltimore Sun, By Julie Bykowicz, March 25, 2009
Senators on a budget subcommittee proposed on Tuesday reducing money for stem cell research – one of several differences from what their counterparts in the House of Delegates recommended. The House’s full budget committee wants to keep $18.4 million in funding for the research, while the Senate’s budget subcommittee on education suggested cutting stem cell grants to $5 million.
Imaging Technique May Trace Development of Parkinson’s Disease
University of Illinois at Chicago Office of Public Affairs, by Paul Francuch, March 24, 2009
While finding a biomarker for Parkinson’s disease that would let physicians screen for or track its progression remains an elusive goal, a team led by a University of Illinois at Chicago neuroscientist has shown that a non-invasive brain scanning technique offers promise.
Obama defends decision on stem cells
Associated Press, March 25, 2009
President Barack Obama said Tuesday that lifting federal restrictions on embryonic stem cell research was the “right thing to do and the ethical thing to do.” The Democratic president said he wrestled with the ethics of the decision but is hopeful that the science will lead to help for people with debilitating diseases.
Experimental Parkinson’s therapy may have robust weight-loss effect
University of Florida News, Filed under Health, Research on Tuesday, March 24, 2009
A growth factor used in clinical experiments to rescue dying brain cells in Parkinson patients may cause unwanted weight loss if delivered to specific areas of the brain, according to University of Florida researchers in the March online edition of Molecular Therapy.
States Consider Harder Line on Stem Cell Research
Fox News, By James Osborne, Tuesday, March 24, 2009
Legislators in Georgia and Oklahoma are considering bills that would limit, if not outright prohibit, scientists from working with human embryonic stem cells in their research to cure or reverse medical conditions, including diabetes, paralysis and Parkinson’s disease. In Texas and Mississippi, lawmakers are considering blocking state funding for that research, mirroring existing laws in other states.
More Than $2 Million From New York State To Fund Stem Cell Research At Rensselaer
Medical News Today, Article Date: 24 Mar 2009 – 2:00 PDT
Two groups of Rensselaer researchers each have received a $1.08 million grant from New York through the state’s stem cell research initiative. Both grants will fund research on the growth and development of stem cells and will provide some of the first insights available into the role specific genes and biological molecules play in stem cell function in the human body.
Human Adult Testes Cells Can Become Embryonic-like
ScienceDaily (Mar. 24, 2009)
Using what they say is a relatively simple method, scientists at Georgetown University Medical Center have extracted stem/progenitor cells from adult testes and have converted them back into pluripotent embryonic-like stem cells. Researchers say that the naïve cells are now potentially capable of morphing into any cell type that a body needs, from brain neurons to pancreatic tissue.
Louisiana: State law forbids embryonic stem-cell research, stunting industry
WWLT, Bigad Shaban / Eyewitness News, 11:24 PM CDT on Monday, March 23, 2009
NEW ORLEANS – The moral debate over embryonic stem-cell research is now an issue of economics in Louisiana. President Obama cleared the way for researchers in the field to now receive federal funding, but some scientists say Louisiana will never see the money.
Hans Keirstead to brief Congress on stem cell research
UCI scientist is behind the field’s first human clinical trial
Today at University of California, Irvine, Calif., March 23, 2009
UC Irvine’s Hans Keirstead – the neurobiologist behind what will be the world’s first human embryonic stem cell clinical trial – will brief Congress on the state of the field 10-11:30 a.m. Tuesday, March 24, in Washington, D.C.
Protein called Shp2 is key to embryonic stem cell differentiation
News-Medical.net, Published: Monday, 23-Mar-2009
Investigators at Burnham Institute for Medical Research (Burnham) have learned that a protein called Shp2 plays a critical role in the pathways that control decisions for differentiation or self-renewal in both human embryonic stem cells (hESCs) and mouse embryonic stem cells (mESCs).
The Empty Promise of Embryonic Stem Cell Research
Why scientific breakthroughs make the destruction of human embryos obsolete.
ChristianityToday, Rep. Mike Pence | posted 3/23/2009 10:51AM
There is no right more fundamental than the right to life. There is no realm in which more exciting progress has been made than that of science. And the two are not inherently opposed to one another.
Profiting from Pluripotency
How companies plan to make money (really) off of embryonic stem cells.
The Scientist, Volume 23 | Issue 2 | Page 6, By Elie Dolgin
What happened? Was therapeutics a doomed fantasy all along? No, say most scientists and analysts, who agree that ESC-based therapies are still attainable in the long run. But how long?
The Real Lessons Of Stem Cells
A Bush veteran weighs in on President Obama’s decision to expand federal funding. Why science could finally end the debate.
Newsweek, By Yuval Levin | NEWSWEEK, Published Mar 21, 2009, From the magazine issue dated Mar 30, 2009
“Embryonic stem cells without embryos? Could it really work?” George W. Bush’s question was directed to me. It was May of 2005, and the president, vice president and half a dozen White House staffers—of whom I was easily the most junior—were gathered in the Oval Office. I was a member of the domestic-policy staff, and the briefing was on the state of the stem-cell debate, which fell in my portfolio.
The Whole World Is Watching
Hope—and anxiety—run high as the first clinical trial of embryonic-stem-cell therapy begins this summer.
Newsweek, By Claudia Kalb | NEWSWEEK, Published Mar 21, 2009, From the magazine issue dated Mar 30, 2009
Six weeks before the hoopla over President Barack Obama’s executive order lifting restrictions on embryonic-stem-cell research, Hans Keirstead, a scientist at the University of California, Irvine, was already sipping champagne.
Stanford Study Improves Insights Into Parkinson’s Disease And Possible Treatments
Medical News Today, Article Date: 22 Mar 2009 – 1:00 PDT
In the new study, which will also appear in an upcoming print issue of Science, the medical and engineering researchers found that by far the biggest effect in “Parkinsonian” rodents occurs not by stimulating cells in the subthalamic nucleus, but by stimulating the neural wires, called axons, that connect directly to it from areas closer to the surface of the brain.
Novel spinal cord stimulator sparks hope for Parkinson’s disease treatment
PhysOrg, March 19th, 2009
A novel stimulation method, the first potential therapy to target the spinal cord instead of the brain, may offer an effective and less invasive approach for Parkinson’s disease tre
Stanford study improves insights into Parkinson’s disease and possible treatments
EurekAlert!, by David Orenstein, Public release date: 19-Mar-2009
About the only thing doctors have understood about deep-brain stimulation, which is widely used to treat Parkinson’s disease symptoms, is that somehow it works for many patients. In a new study that will be published March 19 in the online journal Science Express, Stanford University researchers used light to illuminate how the treatment works, generating surprising insights into the diseased circuitry and also suggesting new ideas to improve Parkinson’s therapy.
Sensors For Use In Parkinson’s Disease Control
Medical News Today, Article Date: 18 Mar 2009 – 2:00 PDT
Companies and organizations from the fields of ICTs, computing, drug engineering and health have joined forces under the joint research project Home-based Empowered Living for Parkinson’s Disease (HELP)…
Renowned Stem Cell Researcher Files Study Results With Stemedica
PR Web, March 18, 2009
Stemedica Cell Technologies, Inc., (“Stemedica”), a leader in adult stem cell research and manufacturing, received the results today from a Stemedica-sponsored clinical study conducted by renowned stem cell researcher and clinician Professor Philippe Hernigou, MD, Ph.D. The approved clinical study featured Dr. Hernigou’s treatment of non-union bone injuries using autologous stem cells, allogeneic stem cells and comparative traditional treatment therapies.
-
Archives
- March 2009 (176)
- February 2009 (115)
-
Categories
- 18162508
- Anti-Depressant
- Bio Tech Industry
- Caregiver
- Clinical Trials
- Coffee
- Depression
- Documentary
- Electronic Medcial Records
- EMEA
- Environmental Causes
- Ethics
- European Medicines Agency
- FDA
- Generic Drugs
- Genetic Mutation
- Genetics
- Health and Human Services Dept
- Healthcare Reform
- HHS
- IRB
- Law
- Legislation
- Lobbying
- Medical Devices
- Medicare
- Mental Health
- MJ Fox
- Neurotoxins
- NHS (United Kingdom)
- NIH
- NIH Funding
- Obama Administration
- Orphan Drugs
- Other Research
- Parkinson's related video
- PD Cause
- PD Clinical Trials
- PD Medical Clinics
- PD Personal Stories
- PD Prevention Research
- PD Research
- PD Support Group News
- PD Surgery
- PD Therapies
- Pharmaceutical Industry
- Prescription Drugs
- PWP In The News
- Religion
- Research with potential for PD
- Social Security
- Social Web Sites
- Stimulus Package
- Stress Effect
- Uncategorized
- YouTube
-
RSS
Entries RSS
Comments RSS
PWP News 